C7H4F2O
142.1 g/mol
Pharmaceutical IntermediateWarning
3,4-Difluorobenzaldehyde
CAS34036-07-2EC422-180-3
Category
Pharmaceutical Intermediate
Compound Class
Aromatic
Primary Use
Pharmaceutical Intermediate
3,4-Difluorobenzaldehyde is a fluorinated aromatic aldehyde used as a pharmaceutical intermediate. Its structure features a benzene ring with two fluorine substituents and an aldehyde group, contributing to its utility in organic synthesis.
Pharmaceutical intermediateBuilding block in organic synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 3,4-Difluorobenzaldehyde?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ReferenceSame Category
(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione
CAS3415-08-5
pharmaceutical intermediate
ReferenceSame Category
(2R,3R,4S,5R)-2-amino-3,4,5,6-tetrahydroxyhexanal
CAS3416-24-8
pharmaceutical intermediate
ReferenceSame Category
Methyl tyrosinate hydrochloride
CAS3417-91-2
pharmaceutical intermediate
ReferenceSame Category
7-bromo-2,3-dichloropyrido[2,3-b]pyrazine
CAS341939-31-9
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H227
H317May cause an allergic skin reaction
H412Harmful to aquatic life with long lasting effects
Identifiers
IUPAC Name
3,4-difluorobenzaldehyde
InChIKey
JPHKMYXKNKLNDF-UHFFFAOYSA-N
SMILES
C1=CC(=C(C=C1C=O)F)F
Synonyms (7)
- 3,4-Difluorobenzaldehyde
- 3,4-diflourobenzaldehyde
- 3,4-difluoro-benzaldehye
- 3,4-difluro-benzaldehyde
- Benzaldehyde, 3,4-difluoro-
- Ticagrelor Impurity 106
- Ticagrelor Impurity 188
Sourcing 3,4-Difluorobenzaldehyde?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.